Combination antiretroviral treatment: new views, evolving practices.
James
J S
JS
D000998:Antiviral Agents / Q000008:administration & dosage* / Q000494:pharmacology; D018791:CD4 Lymphocyte Count / Q000187:drug effects; D002478:Cells, Cultured; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D017277:Drug Approval; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D019259:Lamivudine; D014481:United States; D014486:United States Food and Drug Administration; D016047:Zalcitabine / Q000008:administration & dosage / Q000494:pharmacology; D015215:Zidovudine / Q000008:administration & dosage / Q000494:pharmacology
D000998:Antiviral Agents; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine